Our locations are open for appointments and procedures. See how we're providing safe in-person care and telemedicine visits.

(Nuestras facilidades están abiertas para citas y procedimientos. Vea cómo brindamos atención segura en persona y visitas por medio de telemedicina.)

Learn More (Aprenda Más)
Lung Center

Chronic Obstructive Pulmonary Disease (COPD) Program

A World Leader in COPD Research & Treatment

The Temple Lung Center is one of the world’s most respected research and treatment centers for chronic obstructive pulmonary disease (COPD). Temple’s comprehensive COPD Program has a decades-long history of offering innovative treatments for patients who may have been told they have run out of options. The director of the Temple Lung Center, Gerard Criner, MD, is a recognized thought-leader in COPD research and has helped to write many of the COPD treatment guidelines that are used by physicians worldwide.  

Patient care is at the heart of the Temple Lung Center’s COPD Program. Patients who come to Temple receive a full evaluation by a team of professionals who specialize in properly diagnosing and treating this complex disease. Physicians at Temple can provide a wide variety of treatments for COPD, including:

Patients also have access to emerging therapies through clinical trials.

There is no “one-size-fits-all” care plan at the Temple Lung Center. Rather, Temple’s COPD team looks at each patient and creates a unique treatment plan that is tailored to each patient. This attention to detail extends to educating patients about their disease so that they are empowered to make good choices for the management and treatment of their condition. Temple provides a full slate of educational events, smoking cessation assistance, and support groups. These resources support patients’ emotional health, along with helping them better understand their disease, treatment options and prognosis.

The Temple Lung Center is a leading center for COPD research and is involved in a high volume of clinical trials that are studying new medications, devices and techniques designed to treat COPD. Almost every COPD patient at Temple is eligible for at least one clinical trial.